New Congress To Maintain Focus on PBM Reform
Republican 2022 midterms underperformance is not expected to dampen Congressional Pharmacy Benefit Manager PBM reform. Issue remains at forefront of healthcare pricing debate. No longer seen as Republican-driven effort due to Inflation Reduction Act IRA drug pricing reforms.
Source: natlawreview.com